ProMeris Duo

RSS

Withdrawn

This medicine's authorisation has been withdrawn

metaflumizone / amitraz
MedicineVeterinaryWithdrawn

Italian is available via eTranslation, the European Commission's machine translation service.

Translate to Italian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for ProMeris Duo has been withdrawn at the request of the marketing authorisation holder.

български (BG) (268.89 KB - PDF)

Visualizza

español (ES) (234.19 KB - PDF)

Visualizza

čeština (CS) (263.37 KB - PDF)

Visualizza

dansk (DA) (231.6 KB - PDF)

Visualizza

Deutsch (DE) (237.07 KB - PDF)

Visualizza

eesti (ET) (231.04 KB - PDF)

Visualizza

ελληνικά (EL) (273.19 KB - PDF)

Visualizza

français (FR) (234.85 KB - PDF)

Visualizza

italiano (IT) (230.99 KB - PDF)

Visualizza

latviešu (LV) (271.61 KB - PDF)

Visualizza

lietuvių (LT) (260.01 KB - PDF)

Visualizza

magyar (HU) (258.27 KB - PDF)

Visualizza

Malti (MT) (269.89 KB - PDF)

Visualizza

Nederlands (NL) (232.34 KB - PDF)

Visualizza

polski (PL) (261.12 KB - PDF)

Visualizza

português (PT) (233.54 KB - PDF)

Visualizza

română (RO) (259.96 KB - PDF)

Visualizza

slovenčina (SK) (264.08 KB - PDF)

Visualizza

slovenščina (SL) (250.13 KB - PDF)

Visualizza

suomi (FI) (232.08 KB - PDF)

Visualizza

svenska (SV) (233.25 KB - PDF)

Visualizza

Product information

български (BG) (555.84 KB - PDF)

Visualizza

español (ES) (463.63 KB - PDF)

Visualizza

čeština (CS) (510.99 KB - PDF)

Visualizza

dansk (DA) (459.91 KB - PDF)

Visualizza

Deutsch (DE) (565.04 KB - PDF)

Visualizza

eesti (ET) (467.29 KB - PDF)

Visualizza

ελληνικά (EL) (564.31 KB - PDF)

Visualizza

français (FR) (554.89 KB - PDF)

Visualizza

italiano (IT) (606.2 KB - PDF)

Visualizza

latviešu (LV) (595.88 KB - PDF)

Visualizza

lietuvių (LT) (529.65 KB - PDF)

Visualizza

magyar (HU) (592.54 KB - PDF)

Visualizza

Malti (MT) (547.9 KB - PDF)

Visualizza

Nederlands (NL) (466.67 KB - PDF)

Visualizza

polski (PL) (634.45 KB - PDF)

Visualizza

português (PT) (565.16 KB - PDF)

Visualizza

română (RO) (532.02 KB - PDF)

Visualizza

slovenčina (SK) (543.1 KB - PDF)

Visualizza

slovenščina (SL) (539.48 KB - PDF)

Visualizza

suomi (FI) (477.98 KB - PDF)

Visualizza

svenska (SV) (457.92 KB - PDF)

Visualizza

Íslenska (IS) (462.33 KB - PDF)

Visualizza

norsk (NO) (546.57 KB - PDF)

Visualizza
Latest procedure affecting product information:IB/0011
08/07/2015

български (BG) (197.83 KB - PDF)

Visualizza

español (ES) (145.18 KB - PDF)

Visualizza

čeština (CS) (186.36 KB - PDF)

Visualizza

dansk (DA) (145.68 KB - PDF)

Visualizza

Deutsch (DE) (154.34 KB - PDF)

Visualizza

eesti (ET) (145.19 KB - PDF)

Visualizza

ελληνικά (EL) (198.38 KB - PDF)

Visualizza

français (FR) (145.66 KB - PDF)

Visualizza

italiano (IT) (145.84 KB - PDF)

Visualizza

latviešu (LV) (199.11 KB - PDF)

Visualizza

lietuvių (LT) (184.36 KB - PDF)

Visualizza

magyar (HU) (185.85 KB - PDF)

Visualizza

Nederlands (NL) (145.6 KB - PDF)

Visualizza

polski (PL) (164.96 KB - PDF)

Visualizza

português (PT) (145.14 KB - PDF)

Visualizza

română (RO) (146.57 KB - PDF)

Visualizza

slovenčina (SK) (183.09 KB - PDF)

Visualizza

slovenščina (SL) (162.45 KB - PDF)

Visualizza

suomi (FI) (149.94 KB - PDF)

Visualizza

svenska (SV) (145.54 KB - PDF)

Visualizza

Íslenska (IS) (146.14 KB - PDF)

Visualizza

norsk (NO) (145.55 KB - PDF)

Visualizza

Product details

Name of medicine
ProMeris Duo
Active substance
  • metaflumizone
  • amitraz
International non-proprietary name (INN) or common name
  • metaflumizone
  • amitraz
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QP53AD51

Pharmacotherapeutic group

Ectoparasiticides for topical use, incl. insecticides

Therapeutic indication

For the treatment and prevention of infestations by fleas (Ctenocephalides canis and C. felis), and ticks (Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus, Dermacentor reticulatus and Dermacentor variabilis), and treatment of demodicosis (caused by Demodex spp.) and lice (Trichodectes canis) in dogs.

The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).

Authorisation details

EMA product number
EMEA/V/C/000108
Marketing authorisation holder
Pfizer Limited 

Pfizer Limited
Ramsgate Road
Sandwich
Kent CT13 9NJ
United Kingdom

Marketing authorisation issued
19/12/2006
Revision
7

Assessment history

This page was last updated on

Share this page